RCKT
Rocket Pharmaceuticals, Inc.
Biotechnology · Healthcare · United States
2.44
close · 2026-10-30
value
13
cheaper than peers13
quality
79
stronger fundamentals79
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.72× | 89 |
| earnings yield, 3 years ago | -133.6% | 31 |
| earnings yield, 2 years ago | -119.7% | 29 |
| earnings yield, latest year | -82.4% | 25 |
| earnings yield, 1 year ago | -111.9% | 20 |
| cash flow yield, 3 years ago | -69.7% | 17 |
| cash flow yield, latest year | -71.1% | 17 |
| cash flow yield, 1 year ago | -80.5% | 17 |
| cash flow yield, 2 years ago | -78.9% | 15 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -4.8% | 99 |
| operating margin | 0.0% | 50 |
| debt to equity | 6.7% | 46 |
3 of 4 measures available
Facts
| market cap | $268M |
| free cash flow | $86.1M |
| employees | 202 |
| first trade | 2015-02-18 |
| next earnings | not reported |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.01 | -2.73 | -2.92 | -3.26 |
| free cash flow | -$190.5M | -$215.6M | -$211.4M | -$186.8M |
| net income | -$223.1M | -$258.7M | -$245.6M | -$221.9M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | -$3.2M | $0 | not reported | not reported |